The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 04, 2016
Filed:
May. 29, 2013
Applicant:
Phenex Pharmaceuticals Ag, Ludwigshafen, DE;
Inventors:
Christian Gege, Ehingen, DE;
Olaf Kinzel, Heidelberg, DE;
Christoph Steeneck, Dossenheim, DE;
Gerald Kleymann, Bad Salzuflen, DE;
Thomas Hoffmann, Viernheim, DE;
Assignee:
Phenex Pharmaceuticals AG, Ludwigshafen, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/14 (2006.01); C07D 207/34 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01); C07D 409/12 (2006.01); C07D 401/06 (2006.01); C07D 491/107 (2006.01); C07D 495/10 (2006.01); C07D 413/12 (2006.01); C07D 401/04 (2006.01); C07D 405/04 (2006.01); C07D 249/10 (2006.01);
U.S. Cl.
CPC ...
C07D 207/34 (2013.01); C07D 231/14 (2013.01); C07D 249/10 (2013.01); C07D 401/04 (2013.01); C07D 401/06 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07D 491/107 (2013.01); C07D 495/10 (2013.01);
Abstract
The invention provides modulators for the orphan nuclear receptor RORy and methods for treating RORy mediated diseases by administering these novel RORy modulators to a human or a mammal in need thereof. Specifically, the present invention provides carboxamide containing cyclic compounds of Formula (1) to Formula (5) and the enantiomers, diastereomers, tautomers, /V-oxides, solvates and pharmaceutically acceptable salts thereof.